Cy5 Goat Anti-Mouse IgG (H+L) Workflow
2026-08-14
Build sensitive mouse IgG detection workflows for immunohistochemistry, immunocytochemistry, and flow cytometry with a Cy5-conjugated secondary antibody. This guide translates ferritin-vaccine research into practical fluorescence controls, optimization steps, and troubleshooting decisions.
Balsalazide disodium: colitis research workflows
2026-08-13
Build reproducible ulcerative colitis assays around a colon-targeted 5-ASA prodrug, from aqueous sample preparation to radiolabeled biodistribution studies. The workflow emphasizes literature-backed radioiodination parameters, disease-model interpretation, and practical troubleshooting rather than unsupported mechanistic assumptions.
Alfuzosin HCl: From Receptor Assay to Retention
2026-08-13
Alfuzosin HCl research is strongest when receptor pharmacology, functional urinary-tract endpoints, and dosage-form behavior are interpreted together. This guide examines how MRI-validated gastroretentive sponges can reshape assay and formulation decisions without overstating translational evidence.
1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine for Src Assays
2026-08-13
PP 3 provides a matched negative-control strategy for separating Src-dependent effects from scaffold, vehicle, and pathway-independent responses in kinase and vascular assays. Its value is especially clear when PP2 reduces contraction or signaling but the mechanism must be tested against the L-type calcium-channel findings reported in neonatal arterial research.
From FLCN Rescue to Translational RNA Design
2026-08-12
A mechanistic and strategic guide to using high-yield T7 transcription for FLCN mRNA rescue research. The article interprets recent Birt-Hogg-Dubé findings, translates them into experimental design principles, and explains how the HyperScribe™ T7 High Yield RNA Synthesis Kit Plus can support scalable, customizable RNA workflows while preserving appropriate boundaries between in vitro evidence and clinical translation.
SB 431542 in Human Neuron Assays
2026-08-12
SB 431542 is a selective ALK5 inhibitor that can help resolve how TGF-β pathway activity shapes cell-state phenotypes. This article develops an assay-design framework linking Smad2 readouts with the recently validated human iPSC-derived sensory neuron model of HSV-1 latency, while clearly separating established evidence from exploratory application.
Phosbind Biotin LC: PVDF Detection Guide
2026-08-11
Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes when phospho-specific antibodies are unavailable or insufficient. It is intended for Western Blot workflows using streptavidin-HRP and chemiluminescence, and is not suitable for aqueous-only protocols or long-term storage of working solutions.
Cell Senescence β-Galactosidase Staining Kit
2026-08-10
Learn how Cell Senescence β-Galactosidase Staining Kit, SKU K2185, supports practical SA-β-Gal detection when viability and proliferation assays produce ambiguous results. This scenario-based guide covers assay interpretation, polystyrene compatibility, protocol controls, data reporting, and vendor selection.
Paroxetine Mesylate: SSRI Mechanism and Research Uses
2026-08-09
Paroxetine Mesylate is a Selective serotonin reuptake inhibitor with high-affinity SERT activity and reported secondary effects on CYP2D6, GRK2, MET, and ERBB3. Preclinical colorectal cancer findings and neurocardiac baboon data support distinct research applications, but neither establishes an oncology treatment or SUDEP-prevention indication.
Dibutyryl-cAMP, Sodium Salt: Mechanism & Uses
2026-08-08
Dibutyryl-cAMP, sodium salt is a cell-permeable, stable cAMP analog used to elevate intracellular cAMP and examine PKA-dependent signaling. DBcAMP sodium salt supports cAMP signaling pathway research, but its PDE-inhibitory activity means that responses should not be interpreted as PKA-specific without appropriate controls.
Nilotinib (AMN-107) Assay Guide
2026-08-07
A scenario-based guide to using Nilotinib (AMN-107), SKU A8232, in cell viability, proliferation, and cytotoxicity workflows. It connects BCR-ABL biology with practical decisions about model selection, solvent handling, dosing, endpoint interpretation, and supplier reliability.
Baicalein: Mechanistic and Practical Guide for Cancer Resear
2026-08-07
Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) is a high-purity flavonoid used to inhibit 12-lipoxygenase, modulate inflammation pathways, and study apoptosis in cancer research. Key facts include its molecular weight, solubility, and validated effects on cancer cell proliferation and enzyme regulation. This guide details its protocol parameters, mechanistic rationale, and research applications.
Cyclophilin A Is Essential for Cyclosporine-Mediated Immunos
2026-08-06
This study demonstrates that cyclophilin A is the indispensable intracellular target required for cyclosporine's immunosuppressive effect. Using cyclophilin A-deficient mice, the authors show resistance to cyclosporine, refining mechanistic understanding for transplantation immunology and informing future research on calcineurin inhibitor specificity.
Vorinostat (SAHA): Strategic Epigenetic Modulation in Oncolo
2026-08-06
This thought-leadership article synthesizes mechanistic insight and translational guidance for researchers leveraging Vorinostat (suberoylanilide hydroxamic acid) in cancer biology. Bridging foundational epigenetic biology, advanced apoptosis assays, and emerging cross-talk with non-transcriptional regulation, the article contextualizes Vorinostat’s unique position within the evolving landscape of oncology research. Citing pivotal studies and integrating recent breakthroughs in real-time enzyme activity imaging, it offers actionable recommendations and forward-looking strategies for next-generation experimental design.
METTL17 Regulates Ferroptosis and Tumorigenesis in Colorecta
2026-08-05
The referenced study reveals that the mitochondrial protein METTL17 confers resistance to ferroptosis and promotes tumorigenesis in colorectal cancer by regulating mitochondrial RNA methylation and translation. These findings highlight METTL17 as a promising target to sensitize tumors to ferroptosis-based therapies, providing a mechanistic link between mitochondrial function and cancer cell survival.
467 records 9/32 page Previous Next First page 上5页 678910 下5页 Last page